Bussel JB - Search Results

1

Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura.

Bennett CM, Rogers ZR, Kinnamon DD, Bussel JB, Mahoney DH, Abshire TC, Sawaf H, Moore TB, Loh ML, Glader BE, McCarthy MC, Mueller BU, Olson TA, Lorenzana AN, Mentzer WC, Buchanan GR, Feldman HA, Neufeld EJ. Bennett CM, et al. Among authors: bussel jb. Blood. 2006 Apr 1;107(7):2639-42. doi: 10.1182/blood-2005-08-3518. Epub 2005 Dec 13. Blood. 2006. PMID: 16352811 Free PMC article. Clinical Trial.

2

Autoimmune thrombocytopenic purpura.

Bussel JB. Bussel JB. Hematol Oncol Clin North Am. 1990 Feb;4(1):179-91. Hematol Oncol Clin North Am. 1990. PMID: 1690204 Review.

3

Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect.

Bussel JB, Graziano JN, Kimberly RP, Pahwa S, Aledort LM. Bussel JB, et al. Blood. 1991 May 1;77(9):1884-93. Blood. 1991. PMID: 1850307 Free article. Clinical Trial.

4

Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin.

Bussel JB, Pham LC, Aledort L, Nachman R. Bussel JB, et al. Blood. 1988 Jul;72(1):121-7. Blood. 1988. PMID: 3134063 Free article.

5

Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura.

Bussel JB, Kimberly RP, Inman RD, Schulman I, Cunningham-Rundles C, Cheung N, Smithwick EM, O'Malley J, Barandun S, Hilgartner MW. Bussel JB, et al. Blood. 1983 Aug;62(2):480-6. Blood. 1983. PMID: 6191803 Free article.

6

Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patient.

Soubrane C, Tourani JM, Andrieu JM, Visonneau S, Beldjord K, Israel-Biet D, Mouawad R, Bussel J, Weil M, Khayat D. Soubrane C, et al. Blood. 1993 Jan 1;81(1):15-9. Blood. 1993. PMID: 8093346 Free article.

7

Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production.

Chang M, Suen Y, Meng G, Buzby JS, Bussel J, Shen V, van de Ven C, Cairo MS. Chang M, et al. Blood. 1996 Nov 1;88(9):3354-62. Blood. 1996. PMID: 8896400 Free article.

8

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.

Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB. Scaradavou A, et al. Among authors: bussel jb. Blood. 1997 Apr 15;89(8):2689-700. Blood. 1997. PMID: 9108386 Free article. Clinical Trial.

9

Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group.

Warrier I, Bussel JB, Valdez L, Barbosa J, Beardsley DS. Warrier I, et al. Among authors: bussel jb. J Pediatr Hematol Oncol. 1997 May-Jun;19(3):197-201. doi: 10.1097/00043426-199705000-00004. J Pediatr Hematol Oncol. 1997. PMID: 9201140 Clinical Trial.

10

Recent advances in the treatment of idiopathic thrombocytopenic purpura: the anti-D clinical experience.

Bussel JB. Bussel JB. Semin Hematol. 1998 Jan;35(1 Suppl 1):1-4. Semin Hematol. 1998. PMID: 9523742 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters